Rad AI stock
Private-market facts for current and former Rad AI employees researching their stock.
Overview
Rad AI provides AI-powered radiology software that automates and improves radiology reporting, helping radiologists generate more accurate and consistent reports.
Rad AI outlook
For employees evaluating Rad AI equity, a 1x base multiple suggests the stock may be close to fairly valued at current prices. The upside scenario at 2x is relatively close to the base case, suggesting more predictable but narrower range of outcomes.
These estimates reflect modeled return scenarios, not guaranteed outcomes. Actual results depend on company performance, market conditions, share class, and timing.
Selling Rad AI shares
Why shareholders consider selling
Shareholders in Rad AI may explore liquidity for a number of reasons — diversifying a concentrated position, funding a personal financial goal, or simply reducing exposure to a single private holding. As a private company, Rad AI does not trade on a public exchange, meaning employees and early shareholders cannot simply sell through a brokerage. Extended private timelines can leave shareholders waiting years for an exit event, which is why some choose to explore secondary-market options.
Can you sell Rad AI stock?
Whether a shareholder can sell typically depends on what they hold and how it was acquired. Vested and exercised shares are generally more straightforward than unexercised options or unvested RSUs. Most private companies, including those in the Healthcare & Biotech sector, impose transfer restrictions such as rights of first refusal or board approval requirements. The specific terms governing Rad AI shares would be outlined in the holder's equity agreement or the company's governing documents.
What affects the value of Rad AI shares?
The price a buyer is willing to pay for private shares is shaped by several factors: overall demand for the stock, the company's financial performance, broader Healthcare & Biotech market conditions, and any recent private-market transaction activity. Data points such as the company's Series B round and its reported $2B valuation can help frame expectations, though they do not guarantee a transaction price.
What should holders check before selling
- The type of security held (common shares, preferred, options, RSUs)
- Whether the equity is fully vested and, for options, whether it has been exercised
- Any transfer restrictions, lock-up provisions, or company approval requirements
- Estimated net proceeds after applicable taxes and transaction fees
- Whether partial liquidity — selling a portion rather than the full position — may be a better fit
Tools for Rad AI shareholders
Exploring equity in Rad AI often raises questions about taxes, exercise timing, valuation, and exit outcomes. These tools can help you model different decisions using your own assumptions.
Latest funding round
Rad AI most recently raised a Series B round . The company was valued at $2B. Total funding raised to date is approximately $89M.
Founders & company background
Rad AI was founded in 2018 by Jeff Chang, Doktor Gurson and is headquartered in Berkeley, CA.
Industry
Similar private companies
Latest Rad AI news
Frequently asked questions
- Is Rad AI still a private company?
- Yes, Rad AI is currently a private company.
- What is Rad AI's latest funding round?
- Rad AI's most recent known round is Series B.
- What is Rad AI's valuation?
- Rad AI's latest reported valuation is $2B.
- Who are the investors in Rad AI?
- Investor information is not currently available.
- Can I sell my Rad AI stock?
- Private company shares can sometimes be sold on secondary markets. Speaking with a specialist who understands Rad AI stock can help you evaluate your options.
Related pages
Last verified: 2026-04-13 · Rad AI data compiled from funding disclosures, corporate filings, and public records.
Information on this page is compiled from publicly available sources and may be outdated or incomplete. This is not investment advice. Consult a qualified advisor before making financial decisions.